Results 231 to 240 of about 484,364 (380)
British Journal of Clinical Pharmacology, EarlyView.Aims Casdatifan is an orally bioavailable small‐molecule hypoxia‐inducible factor‐2α (HIF‐2α) inhibitor currently in development for treating patients with clear cell renal cell carcinomas. The aim of this study was to characterize the pharmacokinetics (PK), pharmacodynamics and safety of casdatifan in healthy participants.
Mohammad Ghasemi +11 more
wiley +1 more source
Revolutionizing Chinese medicine granule placebo with a machine learning four-color model. [PDF]
Chin MedTeng T +6 more
europepmc +1 more source
PERSPECTIVES OF THE PLACEBO PHENOMENON: Belief as Pathogen, Belief as Medicine: “Voodoo Death” and the “Placebo Phenomenon” in Anthropological Perspective [PDF]
, 1983 Robert A. Hahn, Arthur Kleinman
openalex +1 more source
British Journal of Clinical Pharmacology, EarlyView.Aims Trial run‐in phases are sometimes used to select adherent participants as a strategy to enrich trials, but the methods employed lack clear regulatory guidance and there are concerns about the transparency of reporting. This review aims to characterize the methods used for adherence measurement and public reporting of run‐in studies.
Non Davies +3 more
wiley +1 more source
Selective Antimicrobial Modulation of the Intestinal Flora of Patients with Acute Nonlymphocytic Leukemia: A Double-Blind, Placebo-Controlled Study [PDF]
, 1983 H. F. L. Guiot +3 more
openalex +1 more source
Placebos, Active Placebos, and Clinical Trials [PDF]
Clinical Therapeutics, 2017 openaire +3 more sources